Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: BAO PHARMA-B(02659) the Revenue is 3.984 M (+60.43%);the EBIT is -107.27 M (-4.95%);the EPS is -0.403 (-5.85%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B60.43%
----
----
EBIT
-0.11B4.95%
----
----
EPS
-0.40355.85%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf